Lamivudine/zidovudine price cut, gefitinib free for poorer patients

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.414, 2003-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine/zidovudine: Mitochondrial toxicity: case report

Reactions Weekly, Vol. 1, Iss. 1276, 2009-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

In utero exposure to lamivudine/zidovudine [Combivir] is associated with mitochondrial damage

Reactions Weekly, Vol. 1, Iss. 1007, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Comparative Studies of Lamivudine-zidovudine Nanoparticles for the Selective Uptake by Macrophages

Current Drug Delivery, Vol. 9, Iss. 5, 2012-09 ,pp. : 506-514

Bentham Science Publishers

Access to resources Recommend Favorite

Lamivudine/zidovudine: Pure red cell aplasia and hypocellular bone marrow: case report

Reactions Weekly, Vol. 1, Iss. 1300, 2010-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Antibacterials/antiretrovirals/ibuprofen: Vanishing bile duct syndrome (first reports with lamivudine/zidovudine, efavirenz, ciprofloxacin, clarithromycin and tenofovir disoproxil fumarate): case report

Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite